BioNTech has obtained exclusive licenses from DualityBio for two investigational antibody-drug conjugate assets that target a wide range of human cancers
Advancing Development of Personalized Antibody-Drug Conjugate Therapies for Solid Tumors
Triazole-Substituted Ethisterones as Anticancer Compounds
Single-step syntheses of derivatives with promising cytotoxic activities
Use of Artificial Intelligence in Drug Development
WACKER, CordenPharma, Munich’s Ludwig Maximilian University (LMU) and the Humboldt University of Berlin train machine learning algorithm to make RNA drugs
Ensuring Ethical Standards in Emerging Technologies
Bayer establishes Bioethics Council comprising of renowned international experts
Silver-Based Terpyridine Complexes as Antitumor Agents
High cytotoxicity against different tumor cells observed
1,3-Diynes as Potent Antifungal Agents
Library of antifungal agents synthesized via Glaser–Hay and Cadiot–Chodkiewicz coupling reactions
Membrane Discs as Antitoxins
Nanodiscs made of erythrocyte membranes neutralize bacterial toxins
Priestley Medal 2023 for Cato Laurencin
Highest honor of the American Chemical Society (ACS) presented to researcher in the field of regenerative engineering
Making Immunizations More Effective
Adjuvants developed using computers boost vaccines
Angewandte Chemie 14/2023: Global Impact
Overview of the latest issue of Angewandte Chemie